FDA.reportPublic FDA data

0.9 ML tocilizumab 180 MG/ML Prefilled Syringe

RxCUI
1441527
RxNorm name
0.9 ML tocilizumab 180 MG/ML Prefilled Syringe
Display name
0.9 ML tocilizumab 180 MG/ML Prefilled Syringe
Full name
0.9 ML tocilizumab 180 MG/ML Prefilled Syringe
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:38:52

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125276Actemratocilizumab351(a)Rx2026-07-01
125472Actemratocilizumab351(a)Rx2026-07-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ACTEMRATOCILIZUMABGenentech, Inc.2e5365ff-cb2a-4b16-b2c7-e35c6bf2de132025-12-16Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1441527

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
2e5365ff-cb2a-4b16-b2c7-e35c6bf2de13tocilizumab 162 MG in 0.9 ML Prefilled Syringe [PSN] · 0.9 ML tocilizumab 180 MG/ML Prefilled Syringe [SCD] · tocilizumab 162 MG per 0.9 ML Prefilled Syringe [SY]353These highlights do not include all the information needed to use ACTEMRA safely and effectively. See full prescribing information for ACTEMRA. ACTEMRA ® (tocilizumab) injection, for intravenous or subcutaneous use Initial U.S. Approval: 201020251216